)
STENOCARE (STENO) investor relations material
STENOCARE Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Achieved three consecutive quarters of positive EBITDA in 2025, marking the first sustained profitability since 2019.
Net sales reached record highs in Q4 2025, with a 36% sequential increase and 107% year-over-year growth.
Strategic exit from Danish cultivation facility and acquisition of CannGros ApS expanded product portfolio and market share.
Financial highlights
Q4 2025 net sales: DKK 2.6 million, up from DKK 1.3 million in Q4 2024.
Full-year 2025 net sales: DKK 7.0 million, up 215% from DKK 2.2 million in 2024; including CannGros, DKK 7.3 million.
Q4 EBITDA: DKK 12,000, positive for the third consecutive quarter; full-year EBITDA: DKK -1.7 million, including DKK -0.8 million in one-time costs.
Q4 personnel expenses reduced by 37% year-over-year; other external expenses down 13%.
Q4 net result: DKK -147,000; full-year net result: DKK -2.4 million, a significant improvement from DKK -34.5 million in 2024.
Outlook and guidance
CannGros acquisition expected to contribute DKK 4–6 million in net sales in 2026.
Anticipates continued growth and profitability, leveraging expanded product portfolio and operational synergies.
- TO2 Warrant share issue funds expansion, product launches, and break-even targets for 2024.STENO
Investor Update3 Feb 2026 - Sales and liquidity under pressure as trading focus and new launches aim to drive recovery.STENO
Q3 202412 Jan 2026 - Record sales and positive EBITDA mark a strong Q3 2025, with growth and cost discipline.STENO
Q3 202522 Oct 2025 - Achieved break-even and 131% sales growth in Q2 2025, with strong regulatory and market momentum.STENO
Q2 202521 Aug 2025 - Sales declined and guidance was lowered, but financial stability and product innovation advanced.STENO
Q2 202413 Jun 2025 - Stenocare pivots to trading, cuts costs, and launches ASTRUM 10-10 amid regulatory wins.STENO
Q1 20255 Jun 2025 - STENOCARE pivots to trading, cuts costs, and secures new markets after Danish legalisation.STENO
Q4 20245 Jun 2025
Next STENOCARE earnings date
Next STENOCARE earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)